Featured Stories

Expanded Immunology Services


Our Edinburgh site has just moved its cell-based assay work into new laboratory facilities and has been developing new approaches in neutralizing antibody (NAb) and antibody-dependent cell-mediated cytotoxicity (ADCC) assays.

Translational Asthma In Vivo Models


With the acquisition of Argenta earlier this year, Charles River's asthma expertise and portfolio has expanded to include unique models that reflect the clinical setting.

Charles River to Maintain the Frederick NCI Facility


As of today, Charles River will assume management and operational responsibilities for the Frederick facility and we will continue to breed and maintain the colonies that are currently housed at this facility.

Argenta and BioFocus Have a New Home at www.criver.com


We are pleased to inform you that www.argentadiscovery.com and www.biofocus.com are now incorporated into the Charles River website, providing you with integrated discovery services information in a single location.

Reinforcing Our Commitment to Humane Care


On May 14, we furthered our commitment to the humane care of research animals by joining our industry colleagues in the signing of the final Concordat on Openness on Animal Research in the UK. 

Fast Track Autoradiography


New rapid, high-resolution and quantitative autoradiography of beta-emitting radioisotopes for preclinical rodent CNS models is now available. The analysis can be done as a stand–alone service or to complement in vivo nuclear imaging with SPECT/CT. 

Displaying results 1-10 (of 115)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >|